"We now have most of the knowledge and tools to end HIV, AIDS and hepatitis C among people who inject drugs in Europe. However, political will and cost remain as top priorities."

Luis Mendão, co-chair of the HIV/AIDS Civil Society Forum

Events & News


Leaflet cover website.png

New Leaflet about Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT)


This new leaflet describes the three-year project, which was launched in late 2015 with core funding from the European Union (EU), and is being implemented by 22 partners representing 18 EU Member States.

The overall aim of HA-REACT is to significantly contribute to the elimination of...

Read more



Upcoming 3rd Partnership Forum

26.10.2017 to 27.10.2017
EMCDDA Conference Centre in Lisbon, Portugal

HA-REACT is organising its 3rd Partnership Forum, in connection with the Lisbon Addictions 2017, the second European Conference on Addictive Behaviors and Dependencies. Associated and collaborating partners, as well as advisors and invited guests, will gather to discuss the progression of the...

Read more


World Cafe.png

“World Café”: Introducing European Joint Actions and Projects


4th Meeting of the ECDC Hepatitis B and C Network and joint meeting with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Drug-Related Infectious Disease (DRID) Network

14 June 2017

During the pan-European infectious disease meeting of the ECDC and EMCDDA,...

Read more

HA-REACT addresses existing gaps in the prevention of HIV and other co-infections, especially TB and viral hepatitis, among people who inject drugs

This three-year project was launched in late 2015 with core funding  from the European Union, and is being implemented by 23 partners in 18 EU Member States.

HA-REACT Advisory Board, 2016










Twitter News